×
For more information, get in touch with our team:
+44 7918 53 08 73
Hint mode is switched on Switch off
For swift navigation between sections

Organization: Bristol Myers Squibb
LEI HLYYNH7UQUORYSJQCN42, Swift BMYPUS33XXX

Issuer name
Bristol-Myers Squibb Company
Country name
USA
Country of registration
USA
Industry
Healthсare
Credit ratings
in foreign currency
  • M/S&P/F
    *** / *** / ***
Bond debt
46,193 mln USD
DATA PLATFORM FOR FINANCIAL MARKET PROFESSIONALS AND INVESTORS
  • High performance interface for global bond market screening
  • Full information on close to 500,000 bonds from 180 countries
  • 100% coverage of Eurobonds worldwide
  • Over 300 primary sources of prices
  • Ratings data from all international and local ratings agencies
  • Stock market data from 100 world trading floors
  • Intuitive, high speed user interface
  • Data access via the website, mobile application and add-in for Microsoft Excel

Latest data on

Profile

Bristol-Myers Squibb Company is a global biopharmaceutical company. The Company develops, licenses, manufactures, markets, and sells pharmaceutical and nutritional products. Bristol-Myers Squibb products and experimental therapies address cancer, heart disease, HIV and AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection, and psychiatric disorders.

Awards

Latest issues

Documentation

Affiliates

Stocks

Bond debt by currency

Codes

  • LEI
    HLYYNH7UQUORYSJQCN42
  • Swift
    BMYPUS33XXX
  • SIC
    2834 PHARMACEUTICAL PREPARATIONS
  • ICB
    4,500 Health Care
  • CIK
    0000014272

Credit ratings

Indices